TITLE:
The Health-Related Quality of Life of Chronic Hepatitis B Virus Carriers Admitted to Yalgado OUEDRAOGO University Hospital, from January 31 to May 31, 2022, Burkina Faso
AUTHORS:
Abdoul-Guaniyi Sawadogo, Abdoul Rasmané Zongo, Hamed Sidwaya Ouedraogo, Ben Moctar Abdou Djibo, Nadine Marie Stella Zombré, Lawagoulé Joseph Emile Ky, Arouna Sessouma, Ramondegue Winde Alphonsine Inès Sawadogo, Stella Line Emmanuella Pare, Roger Sombié
KEYWORDS:
Hepatitis B Virus, Chronic Carrier, Quality of Life, CLDQ-HBV
JOURNAL NAME:
Advances in Infectious Diseases,
Vol.14 No.4,
November
28,
2024
ABSTRACT: Introduction: According to the World Health Organization, chronic hepatitis B is the leading cause of mortality from liver disease and constitutes a public health problem. The aim of this study was to assess the quality of life of chronic hepatitis B virus carriers at the Yalgado OUEDRAOGO University hospital, and to identify the factors associated with this quality of life. Methods: We conducted a cross-sectional study at the Yalgado OUEDRAOGO University Hospital from January 31 to May 31, 2022, among chronic hepatitis B carriers aged at least 18 years who were followed for at least six months, treated or not. Results: The study included 135 patients, with an average age of 41.62 ± 10.69 years and a male predominance (64.44%). The average infection duration was 8.11 years ± 6, and the Chronic Liver Disease Questionnaire - Hepatitis B Virus (CLDQ-HBV) global quality of life score was 5.95 ± 0.90. Respondents’ overall quality of life was linked with gender, history of depression, and history of fatigue (ORa = 0.42 (p = 0.009), ORa = 1.57 (p Conclusion: Our study enabled us to assess mean quality of life scores according to the CLDQ-HBV dimensions, and to identify factors associated with the quality of life of chronic HBV carrier patients. Public health measures such as early diagnosis and management, and free care related to this infection would improve the quality of life of these patients.